- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Advanced Enzyme Technologies Ltd (ADEN)
Advanced Enzyme Technologies Ltd stock price live, this page displays NSE ADEN stock exchange data. View the ADEN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Advanced Enzyme Technologies Ltd real time stock price chart below.
What Is the Advanced Enzyme Technologies Ltd Stock Price Today?
The Advanced Enzyme Technologies Ltd stock price today is 302.35.
What Is the Stock Symbol for Advanced Enzyme Technologies Ltd?
The stock symbol for Advanced Enzyme Technologies Ltd is "ADEN."
What Stock Exchange Does Advanced Enzyme Technologies Ltd Trade On?
Advanced Enzyme Technologies Ltd is listed and trades on the NSE stock exchange.
Is Advanced Enzyme Technologies Ltd a Good Stock to Buy?
Determining whether Advanced Enzyme Technologies Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADEN quote. (ISIN: INE837H01020)
What Is the Advanced Enzyme Technologies Ltd Stock Price Today?
The Advanced Enzyme Technologies Ltd stock price today is 302.35.
What Is the Stock Symbol for Advanced Enzyme Technologies Ltd?
The stock symbol for Advanced Enzyme Technologies Ltd is "ADEN."
What Stock Exchange Does Advanced Enzyme Technologies Ltd Trade On?
Advanced Enzyme Technologies Ltd is listed and trades on the NSE stock exchange.
Is Advanced Enzyme Technologies Ltd a Good Stock to Buy?
Determining whether Advanced Enzyme Technologies Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADEN quote. (ISIN: INE837H01020)
302.35
+2.35(+0.78%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
299.00
305.40
52 wk Range
251.95
419.00
ADEN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
299.00305.40
52 wk Range
251.95419.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.45%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ADEN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
370.00
Upside
+22.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 5 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 370.00
(+22.37% Upside)
Advanced Enzyme Technologies Ltd Earnings Call Summary for Q1/2027
- Q1 FY2027 revenue rose 2% YoY to INR 1,898M, but EBITDA fell 10% to INR 510M amid margin pressure and INR 100M sales reversal impact.
- Stock dropped 9.19% post-results to $294.55 before recovering to $302; trades at P/E of 10.4, below fair value per InvestingPro analysis.
- Management guides full-year revenue growth above 12% with EBITDA margins recovering to 30%, despite softer Q1 start and U.S. market weakness.
- Bioprocessing surged 30% YoY and specialized manufacturing up 41%, offsetting 7% decline in human healthcare segment (60% of revenue).
- Board approved INR 697M buyback starting August 14, 2026 at INR 500/share; plans INR 123 crore capex for R&D and growth initiatives.
Last Updated: 08/12/2026, 08:10 PM
Read Full TranscriptEarnings
Latest Release
Aug 08, 2026
EPS / Forecast
3.31 / --
Revenue / Forecast
2.03B / --
Compare ADEN to Peers and Sector
Metrics to compare | ADEN | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipADENPeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.4x | 24.1x | 4.5x | |
PEG Ratio | 0.97 | −0.14 | 0.00 | |
Price/Book | 2.1x | 0.8x | 1.6x | |
Price / LTM Sales | 4.5x | 0.8x | 1.3x | |
Upside (Analyst Target) | 22.1% | 7.2% | 35.5% | |
Fair Value Upside | Unlock | 2.9% | 0.8% | Unlock |
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain, fungal proteases, and bacterial alpha amylase. It also provides probiotics for human and animal nutrition. In addition, the company offers enzymes and probiotics for fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, oils and fats processing, biofuels, and specialty applications. Further, it provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Advanced Enzyme Tech (ADEN) Stock Price Today?
The Advanced Enzyme Tech stock price today is 302.35 INR.
What Stock Exchange Does Advanced Enzyme Tech Trade On?
Advanced Enzyme Tech is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Advanced Enzyme Tech?
The stock symbol for Advanced Enzyme Tech is "ADEN."
Does Advanced Enzyme Tech Pay Dividends? What’s The Current Dividend Yield?
The Advanced Enzyme Tech dividend yield is 0.45%.
What Is the Advanced Enzyme Tech Market Cap?
As of today, Advanced Enzyme Tech market cap is 33.86B INR.
What Is Advanced Enzyme Tech's Earnings Per Share (TTM)?
The Advanced Enzyme Tech EPS (TTM) is 14.80.
When Is the Next Advanced Enzyme Tech Earnings Date?
Advanced Enzyme Tech will release its next earnings report on Nov 06, 2026.
From a Technical Analysis Perspective, Is ADEN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Advanced Enzyme Tech Stock Split?
Advanced Enzyme Tech has split 1 times.
How Many Employees Does Advanced Enzyme Tech Have?
Advanced Enzyme Tech has 409 employees.
What is the current trading status of Advanced Enzyme Tech (ADEN)?
As of Aug 25, 2026, Advanced Enzyme Tech (ADEN) is trading at a price of 302.35 INR, with a previous close of 302.35 INR. The stock has fluctuated within a day range of 299.00 INR to 305.40 INR, while its 52-week range spans from 251.95 INR to 419.00 INR.
What Is Advanced Enzyme Tech (ADEN) Price Target According to Analysts?
The average 12-month price target for Advanced Enzyme Tech is 370.00 INR, with a high estimate of 370 INR and a low estimate of 370 INR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +22.37% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.